<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-3N9X15ID</identifier><date>2014</date><creator>Petre, Maja</creator><relation>documents/doc/3/URN_NBN_SI_doc-3N9X15ID_001.pdf</relation><relation>documents/doc/3/URN_NBN_SI_doc-3N9X15ID_001.txt</relation><format format_type="issue">2</format><format format_type="volume">65</format><format format_type="type">article</format><format format_type="extent">str. 164-170</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">28106023</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-3N9X15ID</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antikoagulacijsko zdravljenje</subject><subject language_type_id="eng">drug</subject><subject language_type_id="slv">zdravila</subject><title>Clinically important differences between anticoagulation drugs</title><title>Klinično pomembne razlike med antikoagulacijskimi zdravili</title></Record>